Ascendancy Healthcare Announces Distribution Partnership With EffRx

Published: Nov 04, 2013

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

SAN FRANCISCO--(BUSINESS WIRE)--Ascendancy Healthcare, Inc., focused on the commercialization of therapeutic products in China and other high-growth Asian markets, has entered into an agreement with EffRx Pharmaceuticals SA to establish and manage a distribution network for Binosto (alendronate sodium), the first and only buffered effervescent solution for the treatment of osteoporosis. The agreement covers Taiwan, Australia, New Zealand, and certain countries in Southeast Asia. Under the terms of the agreement, Ascendancy will serve as EffRx’s exclusive partner to establish a distribution network for these regions, and will receive milestone payments and royalties from EffRx on distribution sales.

Help employers find you! Check out all the jobs and post your resume.

Back to news